{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:54:24Z","timestamp":1790970864907,"version":"4.1.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012895","name":"Zoetis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-32578-7","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T10:45:38Z","timestamp":1770720338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ex vivo effects of oclacitinib and cyclosporin A on canine immune response to Leishmania infantum"],"prefix":"10.1038","volume":"16","author":[{"given":"Andrea","family":"Murillo-Picco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Jim\u00e9nez-Fortunato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Solano-Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Bardag\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"32578_CR1","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.pt.2017.05.005","volume":"33","author":"G Mir\u00f3","year":"2017","unstructured":"Mir\u00f3, G. et al. Novel areas for prevention and control of canine leishmaniosis. Trends Parasitol. 33, 718\u2013730. https:\/\/doi.org\/10.1016\/j.pt.2017.05.005 (2017).","journal-title":"Trends Parasitol."},{"key":"32578_CR2","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.cvsm.2022.06.012","volume":"52","author":"G Baneth","year":"2022","unstructured":"Baneth, G., Solano-Gallego, L. & Leishmaniasis Vet. Clin. North. Am. Small Anim. Pract. 52, 1359\u20131375. https:\/\/doi.org\/10.1016\/j.cvsm.2022.06.012 (2022).","journal-title":"Vet. Clin. North. Am. Small Anim. Pract."},{"key":"32578_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.vetpar.2014.12.023","volume":"208","author":"MG Pennisi","year":"2015","unstructured":"Pennisi, M. G. Leishmaniosis of companion animals in europe: an update. Vet. Parasitol. 208, 35\u201347. https:\/\/doi.org\/10.1016\/j.vetpar.2014.12.023 (2015).","journal-title":"Vet. Parasitol."},{"key":"32578_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1371\/journal.pntd.0009990","volume":"15","author":"A Bouattour","year":"2021","unstructured":"Bouattour, A. et al. Canine leishmaniosis in Tunisia: Growing prevalence, larger zones of infection. PLoS Negl. Trop. Dis. 15, 12. https:\/\/doi.org\/10.1371\/journal.pntd.0009990 (2021).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"32578_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13071-020-04081-7","volume":"13","author":"R G\u00e1lvez","year":"2020","unstructured":"G\u00e1lvez, R. et al. Latest trends in Leishmania infantum infection in dogs in Spain, part I: Mapped seroprevalence and sand fly distributions. Parasit. Vectors 13, 204. https:\/\/doi.org\/10.1186\/s13071-020-04081-7 (2020).","journal-title":"Parasit. Vectors"},{"key":"32578_CR6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1590\/0037-8682-0429-2017","volume":"51","author":"RBS Silva","year":"2018","unstructured":"Silva, R. B. S. et al. Seroprevalence and risk factors associated with canine visceral leishmaniasis in the state of Para\u00edba, Brazil. Ver. Soc. Bras. Med. 51, 683\u2013688. https:\/\/doi.org\/10.1590\/0037-8682-0429-2017 (2018).","journal-title":"Ver. Soc. Bras. Med."},{"key":"32578_CR7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s13071-015-0991-2","volume":"8","author":"CH Gao","year":"2015","unstructured":"Gao, C. H. et al. Development of a LAMP assay for detection of Leishmania infantum infection in dogs using conjunctival swab samples. Parasit. Vectors. 8, 370. https:\/\/doi.org\/10.1186\/s13071-015-0991-2 (2015).","journal-title":"Parasit. Vectors"},{"key":"32578_CR8","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/vetsci9090482","volume":"9","author":"V Priolo","year":"2022","unstructured":"Priolo, V. et al. Leishmania infantum specific humoral and cellular immune responses in cats and dogs: a comparative cross-sectional study. Vet. Sci. 9, 482. https:\/\/doi.org\/10.3390\/vetsci9090482 (2022).","journal-title":"Vet. Sci."},{"key":"32578_CR9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3389\/fcimb.2019.00427","volume":"9","author":"AAM Gon\u00e7alves","year":"2019","unstructured":"Gon\u00e7alves, A. A. M. et al. An overview of immunotherapeutic approaches against canine visceral leishmaniasis: what has been tested on dogs and a new perspective on improving treatment efficacy. Front. cell. infect. microbiol. 9, 427. https:\/\/doi.org\/10.3389\/fcimb.2019.00427 (2019).","journal-title":"Front. cell. infect. microbiol."},{"key":"32578_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.rvsc.2020.02.004","volume":"130","author":"AJ Toepp","year":"2020","unstructured":"Toepp, A. J. & Petersen, C. A. The balancing act: immunology of leishmaniosis. Res. J. Vet. Sci. 130, 19\u201325. https:\/\/doi.org\/10.1016\/j.rvsc.2020.02.004 (2020).","journal-title":"Res. J. Vet. Sci."},{"key":"32578_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.vetimm.2008.11.020","volume":"128","author":"CF Alves","year":"2009","unstructured":"Alves, C. F. et al. Expression of IFN-\u03b3, TNF-\u03b1, IL-10 and TGF-\u03b2 in lymph nodes associates with parasite load and clinical form of disease in dogs naturally infected with Leishmania (Leishmania) chagasi. Vet. Immunol. Immunopathol. 128, 349\u2013358. https:\/\/doi.org\/10.1016\/j.vetimm.2008.11.020 (2009).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"32578_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-016-1598-y","volume":"9","author":"L Solano-Gallego","year":"2016","unstructured":"Solano-Gallego, L., Montserrat-Sangr\u00e0, S., Ordeix, L. & Mart\u00ednez-Orellana, P. Leishmania infantum-specific production of IFN-\u03b3 and IL-10 in stimulated blood from dogs with clinical leishmaniosis. Parasit. Vectors. 9, 1\u201310. https:\/\/doi.org\/10.1186\/s13071-016-1598-y (2016).","journal-title":"Parasit. Vectors"},{"key":"32578_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1128\/iai.62.1.229-235.1994","volume":"62","author":"E Pinelli","year":"1994","unstructured":"Pinelli, E. et al. Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum. Infect. Immun. 62, 229\u2013235 (1994).","journal-title":"Infect. Immun."},{"key":"32578_CR14","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/pathogens12060821","volume":"12","author":"I Mart\u00ednez-Fl\u00f3rez","year":"2023","unstructured":"Mart\u00ednez-Fl\u00f3rez, I. et al. Effect of local administration of meglumine antimoniate and polyhexamethylene biguanide alone or in combination with a toll-like receptor 4 agonist for the treatment of papular dermatitis due to Leishmania infantum in dogs. Pathogens 12, 821. https:\/\/doi.org\/10.3390\/pathogens12060821 (2023).","journal-title":"Pathogens"},{"key":"32578_CR15","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/infdis\/jiu531","volume":"211","author":"MSL Nascimento","year":"2015","unstructured":"Nascimento, M. S. L. et al. Interleukin 17A acts synergistically with interferon \u03b3 to promote protection against Leishmania infantum infection. J. Infect. Dis. 211, 1015\u20131026. https:\/\/doi.org\/10.1093\/infdis\/jiu531 (2015).","journal-title":"J. Infect. Dis."},{"key":"32578_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1177\/0300985814521248","volume":"51","author":"AF Koutinas","year":"2014","unstructured":"Koutinas, A. F. & Koutinas, C. K. Pathologic mechanisms underlying the clinical findings in canine leishmaniosis due to Leishmania infantum\/chagasi. Vet. Pathol. 51, 527\u2013538. https:\/\/doi.org\/10.1177\/0300985814521248 (2014).","journal-title":"Vet. Pathol."},{"key":"32578_CR17","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.pt.2017.06.004","volume":"33","author":"L Solano-Gallego","year":"2017","unstructured":"Solano-Gallego, L. et al. Diagnostic challenges in the era of canine Leishmania infantum vaccines. Trends Parasitol. 33, 706\u2013717. https:\/\/doi.org\/10.1016\/j.pt.2017.06.004 (2017).","journal-title":"Trends Parasitol."},{"key":"32578_CR18","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.3390\/ANI13101649","volume":"13","author":"M Baxarias","year":"2023","unstructured":"Baxarias, M. et al. Signalment, immunological and parasitological status and clinicopathological findings of Leishmania-seropositive apparently healthy dogs. Animals 13, 1649. https:\/\/doi.org\/10.3390\/ANI13101649 (2023).","journal-title":"Animals"},{"key":"32578_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/jvp.12101","volume":"37","author":"AJ Gonzales","year":"2014","unstructured":"Gonzales, A. J. et al. Oclacitinib (APOQUEL\u00ae) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy. J. Vet. Pharmacol. Ther. 37, 317\u2013324. https:\/\/doi.org\/10.1111\/jvp.12101 (2014).","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"32578_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/vde.13037","volume":"33","author":"C De Martins","year":"2022","unstructured":"De Martins, C. Immunomodulatory effect of long-term oclacitinib maleate therapy in dogs with atopic dermatitis. Vet. Dermatol. 33, 2. https:\/\/doi.org\/10.1111\/vde.13037 (2022).","journal-title":"Vet. Dermatol."},{"key":"32578_CR21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12917-015-0514-6","volume":"11","author":"T Olivry","year":"2015","unstructured":"Olivry, T. et al. Treatment of canine atopic dermatitis: 2015 updated guidelines from the international committee on allergic diseases of animals (ICADA). BMC Vet. Res. 11, 210. https:\/\/doi.org\/10.1186\/s12917-015-0514-6 (2015).","journal-title":"BMC Vet. Res."},{"key":"32578_CR22","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/vde.12976","volume":"32","author":"J Aslan","year":"2021","unstructured":"Aslan, J., Shipstone, M. A. & Sullivan, L. M. Treatment of canine cutaneous epitheliotropic T-cell lymphoma with oclacitinib: a case report. Vet. Dermatol. 32, 398\u2013e113. https:\/\/doi.org\/10.1111\/vde.12976 (2021).","journal-title":"Vet. Dermatol."},{"key":"32578_CR23","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/vde.12458","volume":"28","author":"E Aymeric","year":"2017","unstructured":"Aymeric, E. & Bensignor, E. A case of presumed autoimmune subepidermal blistering dermatosis treated with oclacitinib. Vet. Dermatol. 28, 512\u2013e123. https:\/\/doi.org\/10.1111\/vde.12458 (2017).","journal-title":"Vet. Dermatol."},{"key":"32578_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/vde.13063","volume":"33","author":"N Martinez","year":"2022","unstructured":"Martinez, N., McDonald, B. & Crowley, A. A case report of the beneficial effect of oclacitinib in a dog with pemphigus vulgaris. Vet. Dermatol. 33, 237\u2013e65. https:\/\/doi.org\/10.1111\/vde.13063 (2022).","journal-title":"Vet. Dermatol."},{"key":"32578_CR25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/vde.12852","volume":"31","author":"EJ High","year":"2020","unstructured":"High, E. J. et al. Rapid response of hyperkeratotic erythema multiforme to oclacitinib in two dogs. Vet. Dermatol. 31, 330\u2013e86. https:\/\/doi.org\/10.1111\/vde.12852 (2020).","journal-title":"Vet. Dermatol."},{"key":"32578_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/vde.12743","volume":"30","author":"BJ Levy","year":"2019","unstructured":"Levy, B. J., Linder, K. E. & Olivry, T. The role of oclacitinib in the management of ischaemic dermatopathy in four dogs. Vet. Dermatol. 30, 201\u2013e63. https:\/\/doi.org\/10.1111\/vde.12743 (2019).","journal-title":"Vet. Dermatol."},{"key":"32578_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/vde.13128","volume":"34","author":"RG Harvey","year":"2023","unstructured":"Harvey, R. G., Olivr\u012b, A., Lima, T. & Olivry, T. Effective treatment of canine chronic cutaneous lupus erythematosus variants with oclacitinib: seven cases. Vet. Dermatol. 34, 53\u201358. https:\/\/doi.org\/10.1111\/vde.13128 (2023).","journal-title":"Vet. Dermatol."},{"key":"32578_CR28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/vde.12992","volume":"32","author":"S Colombo","year":"2021","unstructured":"Colombo, S., Cornegliani, L., Vercelli, A. & Fondati, A. Ear tip ulcerative dermatitis treated with oclacitinib in 25 dogs: a retrospective case series. Vet. Dermatol. 32, 363\u2013e100. https:\/\/doi.org\/10.1111\/vde.12992 (2021).","journal-title":"Vet. Dermatol."},{"key":"32578_CR29","doi-asserted-by":"publisher","unstructured":"Hernandez-Bures, A., Bidot, W. A., Griffin, C. E. & Rosenkrantz, W. S. The use of oclacitinib compared to azathioprine in the management of canine pemphigus foliaceus: a retrospective analysis. Vet. Dermatol. 34, 554\u2013566. (2023). https:\/\/doi.org\/10.1111\/vde.13203 (2023).","DOI":"10.1111\/vde.13203"},{"key":"32578_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/vr.102471","volume":"174","author":"T Nuttall","year":"2014","unstructured":"Nuttall, T., Reece, D. & Roberts, E. Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis. Vet. Rec. 174, 3\u201312. https:\/\/doi.org\/10.1136\/vr.102471 (2014).","journal-title":"Vet. Rec"},{"key":"32578_CR31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.cvsm.2022.01.009","volume":"52","author":"KR Viviano","year":"2022","unstructured":"Viviano, K. R. Glucocorticoids, cyclosporine, azathioprine, chlorambucil, and mycophenolate in dogs and cats: clinical uses, pharmacology, and side effects. Vet. Clin. North. Am. Small Anim. Pract. 52, 797\u2013817. https:\/\/doi.org\/10.1016\/j.cvsm.2022.01.009 (2022).","journal-title":"Vet. Clin. North. Am. Small Anim. Pract."},{"key":"32578_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1939-1676.2006.tb02852.x","volume":"20","author":"K Allenspach","year":"2006","unstructured":"Allenspach, K. et al. Pharmacokinetics and clinical efficacy of cyclosporine treatment of dogs with steroid-refractory inflammatory bowel disease. J. Vet. Intern. Med. 20, 239\u2013244. https:\/\/doi.org\/10.1111\/j.1939-1676.2006.tb02852.x (2006).","journal-title":"J. Vet. Intern. Med."},{"key":"32578_CR33","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/jvim.15463","volume":"33","author":"JW Swann","year":"2019","unstructured":"Swann, J. W. et al. ACVIM consensus statement on the treatment of immune-mediated hemolytic anemia in dogs. J. Vet. Intern. Med. 33, 1141\u20131172. https:\/\/doi.org\/10.1111\/jvim.15463 (2019).","journal-title":"J. Vet. Intern. Med."},{"key":"32578_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1476-4431.2011.00705.x","volume":"22","author":"RK Nakamura","year":"2012","unstructured":"Nakamura, R. K., Tompkins, E. & Bianco, D. Therapeutic options for immune-mediated thrombocytopenia. J. Vet. Emerg. Crit. Care. 22, 59\u201372. https:\/\/doi.org\/10.1111\/j.1476-4431.2011.00705.x (2012).","journal-title":"J. Vet. Emerg. Crit. Care"},{"key":"32578_CR35","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2460\/javma.248.4.395","volume":"248","author":"AC Rhoades","year":"2016","unstructured":"Rhoades, A. C., Vernau, W., Kass, P. H., Herrera, M. A. & Sykes, J. E. Comparison of the efficacy of prednisone and cyclosporine for treatment of dogs with primary immune-mediated polyarthritis. J. Am. Vet. Med. Assoc. 248, 395\u2013404 (2016).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"32578_CR36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/08820139.2019.1571506","volume":"48","author":"N Keyhanmehr","year":"2019","unstructured":"Keyhanmehr, N., Motedayyen, H. & Eskandari, N. The effects of Silymarin and cyclosporine A on the proliferation and cytokine production of regulatory T cells. Immunol. Invest. 48, 533\u2013548. https:\/\/doi.org\/10.1080\/08820139.2019.1571506 (2019).","journal-title":"Immunol. Invest."},{"key":"32578_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1365-3164.2004.00376.x","volume":"15","author":"E Guagu\u00e8re","year":"2004","unstructured":"Guagu\u00e8re, E., Steffan, J., Olivry, T. & Cyclosporin, A. A new drug in the field of canine dermatology. Vet. Dermatol. 15, 61\u201374. https:\/\/doi.org\/10.1111\/j.1365-3164.2004.00376.x (2004).","journal-title":"Vet. Dermatol."},{"key":"32578_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.vetimm.2018.01.003","volume":"197","author":"TM Archer","year":"2018","unstructured":"Archer, T. M. et al. In vivo effects of aspirin and cyclosporine on regulatory T cells and T-cell cytokine production in healthy dogs. Vet. Immunol. Immunopathol. 197, 63\u201368. https:\/\/doi.org\/10.1016\/j.vetimm.2018.01.003 (2018).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"32578_CR39","doi-asserted-by":"publisher","unstructured":"Fellman, C. L., Archer, T. M., Wills, R. W. & Mackin, A. J. Effects of cyclosporine and dexamethasone on canine T cell expression of interleukin-2 and interferon-gamma. Vet. Immunol. Immunopathol. 216, 109892. (2019). https:\/\/doi.org\/10.1016\/j.vetimm.2019.109892 (2019).","DOI":"10.1016\/j.vetimm.2019.109892"},{"key":"32578_CR40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.vetimm.2010.11.005","volume":"140","author":"CL Fellman","year":"2011","unstructured":"Fellman, C. L. et al. Cyclosporine A affects the in vitro expression of T cell activation-related molecules and cytokines in dogs. Vet. Immunol. Immunopathol. 140, 175\u2013180. https:\/\/doi.org\/10.1016\/j.vetimm.2010.11.005 (2011).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"32578_CR41","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1093\/ndt\/17.9.1568","volume":"17","author":"J Waiser","year":"2002","unstructured":"Waiser, J. et al. Cyclosporine A up-regulates the expression of TGF-\u03b21 and its receptors type I and type II in rat mesangial cells. Nephrol. Dial Transpl. 17, 1568\u20131577 (2002). https:\/\/academic.oup.com\/ndt\/article\/17\/9\/1568\/1903982","journal-title":"Nephrol. Dial Transpl."},{"key":"32578_CR42","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13071-022-05246-2","volume":"15","author":"M Baxarias","year":"2022","unstructured":"Baxarias, M., Vi\u00f1als, J., \u00c1lvarez-Fern\u00e1ndez, A., Alcover, M. M. & Solano-Gallego, L. Detection of specific antibodies against Leishmania infantum in canine serum and oral transudate using an in-house ELISA. Parasit. Vectors. 15, 164. https:\/\/doi.org\/10.1186\/s13071-022-05246-2 (2022).","journal-title":"Parasit. Vectors"},{"key":"32578_CR43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1756-3305-7-111","volume":"7","author":"L Solano-Gallego","year":"2014","unstructured":"Solano-Gallego, L. et al. Serological diagnosis of canine leishmaniosis: comparison of three commercial ELISA tests (Leiscan, ID screen and leishmania 96), a rapid test (Speed Leish K) and an in-house IFAT. Parasit. Vectors. 7, 111. https:\/\/doi.org\/10.1186\/1756-3305-7-111 (2014).","journal-title":"Parasit. Vectors"},{"key":"32578_CR44","doi-asserted-by":"publisher","first-page":"e0004179","DOI":"10.1371\/journal.pntd.0004179","volume":"9","author":"E Carrillo","year":"2015","unstructured":"Carrillo, E. et al. Cytokine release assays as tests for exposure to Leishmania, and for confirming cure from leishmaniasis, in solid organ transplant recipients. PLoS Negl. Trop. Dis. 9, e0004179. https:\/\/doi.org\/10.1371\/journal.pntd.0004179 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"32578_CR45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/vde.12698","volume":"30","author":"F Banovic","year":"2019","unstructured":"Banovic, F., Tarigo, J., Gordon, H., Barber, J. P. & Gogal, R. M. Immunomodulatory in vitro effects of oclacitinib on canine T-cell proliferation and cytokine production. Vet. Dermatol. 30, 17\u2013e6. https:\/\/doi.org\/10.1111\/vde.12698 (2019).","journal-title":"Vet. Dermatol."},{"key":"32578_CR46","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/J.JIM.2010.01.014","volume":"356","author":"H Kloverpris","year":"2010","unstructured":"Kloverpris, H. et al. Dimethyl sulfoxide (DMSO) exposure to human peripheral blood mononuclear cells (PBMCs) abolish T cell responses only in high concentrations and following coincubation for more than two hours. J. Immunol. Methods. 356, 70\u201378. https:\/\/doi.org\/10.1016\/J.JIM.2010.01.014 (2010).","journal-title":"J. Immunol. Methods"},{"key":"32578_CR47","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1365-3164.2012.01064.x","volume":"24","author":"LL Gray","year":"2013","unstructured":"Gray, L. L., Hillier, A., Cole, L. K. & Rajala-Schultz, P. J. The effect of ketoconazole on whole blood and skin ciclosporin concentrations in dogs. Vet. Dermatol. 24, 118\u2013e28. https:\/\/doi.org\/10.1111\/j.1365-3164.2012.01064.x (2013).","journal-title":"Vet. Dermatol."},{"key":"32578_CR48","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/VETSCI9030116","volume":"9","author":"P Mart\u00ednez-Orellana","year":"2022","unstructured":"Mart\u00ednez-Orellana, P. et al. Humoral responses and ex vivo IFN-\u03b3 production after canine whole blood stimulation with Leishmania infantum antigen or KMP11 recombinant protein. Vet. Sci. 9, 116. https:\/\/doi.org\/10.3390\/VETSCI9030116 (2022).","journal-title":"Vet. Sci."},{"key":"32578_CR49","unstructured":"The jamovi project. jamovi. (Version 2.3) [Computer Software]. (2022). Retrieved from https:\/\/www.jamovi.org"},{"key":"32578_CR50","unstructured":"R Core Team. R: A Language and environment for statistical computing. (Version 4.1) [Computer software]. (2021). Retrieved from https:\/\/cran.r-project.org. (R packages retrieved from MRAN snapshot 2022-01-01)."},{"key":"32578_CR51","unstructured":"Singmann, H. afex: Analysis of Factorial Experiments. [R package]. (2018). Retrieved from https:\/\/cran.r-project.org\/package=afex"},{"key":"32578_CR52","unstructured":"Lenth, R. emmeans: Estimated Marginal Means, aka Least-Squares Means. [R package]. (2020). Retrieved from https:\/\/cran.r-project.org\/package=emmeans"},{"key":"32578_CR53","unstructured":"GraphPad & Software Boston, Massachusetts USA, www.graphpad.com."},{"key":"32578_CR54","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/vde.13253","volume":"35","author":"HL Tham","year":"2024","unstructured":"Tham, H. L. & Davis, J. L. Pharmacology of drugs used in autoimmune dermatopathies in cats and dogs: a narrative review. Vet. Dermatol. 35, 453\u2013476. https:\/\/doi.org\/10.1111\/vde.13253 (2024).","journal-title":"Vet. Dermatol."},{"key":"32578_CR55","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/jvim.15729","volume":"34","author":"TM Archer","year":"2020","unstructured":"Archer, T. M. et al. Effects of oral administration of 5 immunosuppressive agents on activated T-cell cytokine expression in healthy dogs. J. Vet. Intern. Med. 34, 1206\u20131213. https:\/\/doi.org\/10.1111\/jvim.15729 (2020).","journal-title":"J. Vet. Intern. Med."},{"key":"32578_CR56","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/vde.13140","volume":"34","author":"I Herrmann","year":"2023","unstructured":"Herrmann, I. et al. Long-term effects of ciclosporin and oclacitinib on mediators of tolerance, regulatory T-cells, IL-10 and TGF-\u03b2, in dogs with atopic dermatitis. Vet. Dermatol. 34, 107\u2013114. https:\/\/doi.org\/10.1111\/vde.13140 (2023).","journal-title":"Vet. Dermatol."},{"key":"32578_CR57","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/jvp.12762","volume":"42","author":"C Riggs","year":"2019","unstructured":"Riggs, C. et al. Alterations in activated T-cell cytokine expression in healthy dogs over the initial 7 days of twice daily dosing with oral cyclosporine. J. Vet. Pharmacol. Ther. 42, 385\u2013391. https:\/\/doi.org\/10.1111\/jvp.12762 (2019).","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"32578_CR58","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/vms3.143","volume":"5","author":"JRS Dandrieux","year":"2019","unstructured":"Dandrieux, J. R. S., Narayanan, L., Firestone, S., Archer, T. M. & Mansfield, C. S. Effect of immunosuppressive drugs on cytokine production in canine whole blood stimulated with lipopolysaccharide or a combination of ionomycin and phorbol 12-myristate 13-acetate. Vet. Med. Sci. 5, 199\u2013205. https:\/\/doi.org\/10.1002\/vms3.143 (2019).","journal-title":"Vet. Med. Sci."},{"key":"32578_CR59","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/jvp.12280","volume":"39","author":"CL Fellman","year":"2016","unstructured":"Fellman, C. L. et al. Effects of oral cyclosporine on canine T-cell expression of IL-2 and IFN-gamma across a 12-h dosing interval. J. Vet. Pharmacol. Ther. 39, 237\u2013244. https:\/\/doi.org\/10.1111\/jvp.12280 (2016).","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"32578_CR60","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1111\/j.1939-1676.2011.00797.x","volume":"25","author":"TM Archer","year":"2011","unstructured":"Archer, T. M. et al. Pharmacodynamic monitoring of canine T-cell cytokine responses to oral cyclosporine. J. Vet. Intern. Med. 25, 1391\u20131397. https:\/\/doi.org\/10.1111\/j.1939-1676.2011.00797.x (2011).","journal-title":"J. Vet. Intern. Med."},{"key":"32578_CR61","first-page":"1283","volume":"61","author":"EJ High","year":"2020","unstructured":"High, E. J. & Olivry, T. The prevalence of bacterial infections during cyclosporine therapy in dogs: a critically appraised topic. Can. Vet. J. 61, 1283\u20131289 (2020). www.bestbetsforvets.org\/about-bets","journal-title":"Can. Vet. J."},{"key":"32578_CR62","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1365-3164.2005.00435.x","volume":"16","author":"SN Radowicz","year":"2005","unstructured":"Radowicz, S. N. & Power, H. T. Long-term use of cyclosporine in the treatment of canine atopic dermatitis. Vet. Dermatol. 16, 81\u201386. https:\/\/doi.org\/10.1111\/j.1365-3164.2005.00435.x (2005).","journal-title":"Vet. Dermatol."},{"key":"32578_CR63","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1111\/jvim.14824","volume":"31","author":"BB McAtee","year":"2017","unstructured":"McAtee, B. B. et al. Opportunistic invasive cutaneous fungal infections associated with administration of cyclosporine to dogs with immune-mediated disease. J. Vet. Intern. Med. 31, 1724\u20131729. https:\/\/doi.org\/10.1111\/jvim.14824 (2017).","journal-title":"J. Vet. Intern. Med."},{"key":"32578_CR64","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.kint.2021.07.028","volume":"101","author":"D Rodr\u00edguez-Espinosa","year":"2022","unstructured":"Rodr\u00edguez-Espinosa, D. et al. The case persistent fever in a hemodialysis patient. Kidney Int. 101, 193\u2013194. https:\/\/doi.org\/10.1016\/j.kint.2021.07.028 (2022).","journal-title":"Kidney Int."},{"key":"32578_CR65","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s12879-017-2571-x","volume":"17","author":"G Darcis","year":"2017","unstructured":"Darcis, G. et al. Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy. BMC Infect. Dis. 17, 478. https:\/\/doi.org\/10.1186\/s12879-017-2571-x (2017).","journal-title":"BMC Infect. Dis."},{"key":"32578_CR66","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1177\/20551169221109442","volume":"8","author":"J Webster","year":"2022","unstructured":"Webster, J., Marchesi, F., Gunn-Moore, D., Haining, H. & Ridyard, A. E. Disseminated Mycobacterium avium infection in a cat on long-term ciclosporin therapy and potential latent infection of an in-contact cat. J. Feline Med. Surg. Open. Rep. 8, 2. https:\/\/doi.org\/10.1177\/20551169221109442 (2022).","journal-title":"J. Feline Med. Surg. Open. Rep."},{"key":"32578_CR67","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/jsap.12367","volume":"57","author":"SR Dowling","year":"2016","unstructured":"Dowling, S. R. et al. Opportunistic fungal infections in dogs treated with ciclosporin and glucocorticoids: eight cases. J. Small Anim. Pract. 57, 105\u2013109. https:\/\/doi.org\/10.1111\/jsap.12367 (2016).","journal-title":"J. Small Anim. Pract."},{"key":"32578_CR68","doi-asserted-by":"publisher","first-page":"100542","DOI":"10.1016\/j.vprsr.2021.100542","volume":"23","author":"H Salant","year":"2021","unstructured":"Salant, H. et al. Systemic toxoplasmosis in a cat under cyclosporine therapy. Vet. Parasitol. Reg. Stud. Rep. 23, 100542. https:\/\/doi.org\/10.1016\/j.vprsr.2021.100542 (2021).","journal-title":"Vet. Parasitol. Reg. Stud. Rep."},{"key":"32578_CR69","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","volume":"18","author":"LB Ivashkiv","year":"2018","unstructured":"Ivashkiv, L. B. IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat. Rev. Immunol. 18, 545\u2013558. https:\/\/doi.org\/10.1038\/s41577-018-0029-z (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"32578_CR70","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.semcdb.2008.08.010","volume":"19","author":"C Schindler","year":"2008","unstructured":"Schindler, C. & Plumlee, C. Inteferons pen the JAK-STAT pathway. Semin Cell. Dev. Biol. 19, 311\u2013318. https:\/\/doi.org\/10.1016\/j.semcdb.2008.08.010 (2008).","journal-title":"Semin Cell. Dev. Biol."},{"key":"32578_CR71","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1002\/tox.23818","volume":"38","author":"CY Lu","year":"2023","unstructured":"Lu, C. Y. et al. Ohwia caudata extract relieves the IL-17A-induced inflammatory response of synoviocytes through modulation of SOCS3 and JAK2\/STAT3 activation. Environ. Toxicol. 38, 1914\u20131924. https:\/\/doi.org\/10.1002\/tox.23818 (2023).","journal-title":"Environ. Toxicol."},{"key":"32578_CR72","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.intimp.2014.01.027","volume":"19","author":"Y Xu","year":"2014","unstructured":"Xu, Y., Xu, X., Gao, X., Chen, H. & Geng, L. Shikonin suppresses IL-17-induced VEGF expression via blockage of JAK2\/STAT3 pathway. Int. Immunopharmacol. 19, 327\u2013333. https:\/\/doi.org\/10.1016\/j.intimp.2014.01.027 (2014).","journal-title":"Int. Immunopharmacol."},{"key":"32578_CR73","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jcpa.2015.10.174","volume":"153","author":"MSL Nascimento","year":"2015","unstructured":"Nascimento, M. S. L. et al. Impairment of interleukin-17a expression in canine visceral leishmaniosis is correlated with reduced interferon-\u03b3 and inducible nitric oxide synthase expression. J. Comp. Pathol. 153, 197\u2013205. https:\/\/doi.org\/10.1016\/j.jcpa.2015.10.174 (2015).","journal-title":"J. Comp. Pathol."},{"key":"32578_CR74","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1371\/journal.pntd.0001703","volume":"6","author":"GK Katara","year":"2012","unstructured":"Katara, G. K., Ansari, N. A., Singh, A., Ramesh, V. & Salotra, P. Evidence for involvement of Th17 type responses in post Kala Azar dermal leishmaniasis (PKDL). PLOS Negl. Trop. Dis. 6, 6. https:\/\/doi.org\/10.1371\/journal.pntd.0001703 (2012).","journal-title":"PLOS Negl. Trop. Dis."},{"key":"32578_CR75","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1172\/JCI38813","volume":"119","author":"MGR Pitta","year":"2009","unstructured":"Pitta, M. G. R. et al. IL-17 and IL-22 are associated with protection against human Kala Azar caused by Leishmania donovani. J. Clin. Invest. 119, 2379\u20132387. https:\/\/doi.org\/10.1172\/JCI38813 (2009).","journal-title":"J. Clin. Invest."},{"key":"32578_CR76","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1084\/jem.20051044","volume":"202","author":"SH Eun","year":"2005","unstructured":"Eun, S. H., Hong, J. H. & Glimcher, L. H. IL-2 production in developing Th1 cells is regulated by heterodimerization of rela and T-bet and requires T-bet Serine residue 508. J. Exp. Med. 202, 1289\u20131300. https:\/\/doi.org\/10.1084\/jem.20051044 (2005).","journal-title":"J. Exp. Med."},{"key":"32578_CR77","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jcpa.2011.03.001","volume":"145","author":"MAG Barbosa","year":"2011","unstructured":"Barbosa, M. A. G. et al. Cytokine gene expression in the tissues of dogs infected by Leishmania infantum. J. Comp. Pathol. 145, 336\u2013344. https:\/\/doi.org\/10.1016\/j.jcpa.2011.03.001 (2011).","journal-title":"J. Comp. Pathol."},{"key":"32578_CR78","doi-asserted-by":"publisher","first-page":"100861","DOI":"10.1016\/j.vprsr.2023.100861","volume":"40","author":"M Maci\u00e0","year":"2023","unstructured":"Maci\u00e0, M., Mar\u00edn-Garc\u00eda, P. J., Ahuir-Baraja, A. E. & Llobat, L. Immunological profile of two canine breeds in an endemic region of Leishmania infantum. Vet. Parasitol. Reg. Stud. Rep. 40, 100861. https:\/\/doi.org\/10.1016\/j.vprsr.2023.100861 (2023).","journal-title":"Vet. Parasitol. Reg. Stud. Rep."},{"key":"32578_CR79","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0165-2427(99)00048-3","volume":"69","author":"E Pinelli","year":"1999","unstructured":"Pinelli, E. et al. Detection of canine cytokine gene expression by reverse transcription-polymerase chain reaction. Vet. Immunol. Immunopathol. 69, 121\u2013126 (1999).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"32578_CR80","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.actatropica.2013.04.005","volume":"127","author":"MEB Santiago","year":"2013","unstructured":"Santiago, M. E. B. et al. Improvement in clinical signs and cellular immunity of dogs with visceral leishmaniasis using the immunomodulator P-MAPA. Acta Trop. 127, 174\u2013180. https:\/\/doi.org\/10.1016\/j.actatropica.2013.04.005 (2013).","journal-title":"Acta Trop."},{"key":"32578_CR81","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0165-2427(02)00134-4","volume":"88","author":"GM Santos-Gomes","year":"2002","unstructured":"Santos-Gomes, G. M. et al. Cytokine expression during the outcome of canine experimental infection by Leishmania infantum. Vet. Immunol. Immunopathol. 88, 21\u201330 (2002).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"32578_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.05.021","author":"AV Ibarra-Meneses","year":"2016","unstructured":"Ibarra-Meneses, A. V. et al. Interleukin-2 as a marker for detecting asymptomatic individuals in areas where Leishmania infantum is endemic. Clin. Microbiol. Infect. 22 https:\/\/doi.org\/10.1016\/j.cmi.2016.05.021 (2016). 739.e1\u2013739.e4."},{"key":"32578_CR83","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.pt.2012.08.007","volume":"28","author":"F Dantas-Torres","year":"2012","unstructured":"Dantas-Torres, F. et al. Canine leishmaniosis in the old and new worlds: unveiled similarities and differences. Trends Parasitol. 28, 531\u2013538. https:\/\/doi.org\/10.1016\/j.pt.2012.08.007 (2012).","journal-title":"Trends Parasitol."},{"key":"32578_CR84","doi-asserted-by":"publisher","unstructured":"Desquesnes, M., Ravel, S., Deschamps, J. Y., Polack, B. & Roux, F. Atypical hyperpachymorph Trypanosoma (Nannomonas) congolense forest-type in a dog returning from Senegal. Parasite 19, 239\u2009\u2013\u200947. (2012). https:\/\/doi.org\/10.1051\/parasite\/2012193239","DOI":"10.1051\/parasite\/2012193239"},{"key":"32578_CR85","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/vr.d888","volume":"168","author":"K Museux","year":"2011","unstructured":"Museux, K., Boulouha, L., Majani, S. & Journaux, H. African Trypanosoma infection in a dog in France. Vet. Rec. 168, 590. https:\/\/doi.org\/10.1136\/vr.d888 (2011).","journal-title":"Vet. Rec"},{"key":"32578_CR86","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1939-165X.2012.00454.x","volume":"41","author":"M Defontis","year":"2012","unstructured":"Defontis, M. et al. Canine Trypanosoma evansi infection introduced into Germany. Vet. Clin. Pathol. 41, 369\u2013374. https:\/\/doi.org\/10.1111\/j.1939-165X.2012.00454.x (2012).","journal-title":"Vet. Clin. Pathol."},{"key":"32578_CR87","doi-asserted-by":"publisher","first-page":"106827","DOI":"10.1016\/j.actatropica.2023.106827","volume":"239","author":"WF Siqueira","year":"2023","unstructured":"Siqueira, W. F. et al. Serodiagnosis of leishmaniasis in asymptomatic and symptomatic dogs by use of the recombinant dynamin-1-like protein from Leishmania infantum: A preliminary study. Acta Trop. 239, 106827. https:\/\/doi.org\/10.1016\/j.actatropica.2023.106827 (2023).","journal-title":"Acta Trop."},{"key":"32578_CR88","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1590\/0037-8682-0291-2014","volume":"48","author":"FS Krawczak","year":"2015","unstructured":"Krawczak, F. S. et al. Leishmania, Babesia and Ehrlichia in urban pet dogs: co-infection or cross-reaction in serological methods? Rev. Soc. Bras. Med. Trop. 48, 64\u201368. https:\/\/doi.org\/10.1590\/0037-8682-0291-2014 (2015).","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"32578_CR89","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1590\/0037-8682-1723-2013","volume":"47","author":"MF Zanette","year":"2014","unstructured":"Zanette, M. F. et al. Serological cross-reactivity of Trypanosoma cruzi, Ehrlichia canis, Toxoplasma gondii, Neospora Caninum and Babesia canis to Leishmania infantum\u00a0chagasi tests in dogs. Rev. Soc. Bras. Med. Trop. 47, 105\u2013107. https:\/\/doi.org\/10.1590\/0037-8682-1723-2013 (2014).","journal-title":"Rev. Soc. Bras. Med. Trop."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32578-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32578-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32578-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:02:43Z","timestamp":1772578963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32578-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["32578"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32578-7","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.cmi.2016.05.021","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MB has received honoraria for lectures and Advisory Boards from Zoetis Inc. All other authors declare no relevant competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8016"}}